Health

Patient Versus Algorithm

Patient Versus Algorithm

Scholars propose enabling patients to sue the makers and providers of discriminatory health care algorithms.

Are Older Adults Being Protected?

Are Older Adults Being Protected?

Experts offer analysis and policy ideas to promote the independence and well-being of older adults.

The Troubled Teen Industry’s Troubling Lack of Oversight

The Troubled Teen Industry’s Troubling Lack of Oversight

The federal government must step in to regulate an industry fraught with youth abuse.

Bringing Professional Regulation Into the Future

Bringing Professional Regulation Into the Future

Ireland’s Chief Nursing Officer endorses a flexible and compassionate approach to health care regulation.

Cracking Down on Overdose Deaths

Cracking Down on Overdose Deaths

FDA approves first over-the-counter treatment to combat the opioid overdose epidemic.

Patent Law Could Also Limit Mifepristone Access

Patent Law Could Also Limit Mifepristone Access

Existing patents deter the marketing of more affordable generic drugs that could be used off-label for abortions.

FDA’s Role in Access to Reproductive Health Care

FDA’s Role in Access to Reproductive Health Care

Recent abortion pill litigation underscores the significance of calls to make birth control pills available over the counter.

Bettering Behavioral Health

Bettering Behavioral Health

Scholars examine regulatory solutions for improving behavioral health care.

Regulating to Improve Methadone Access

Regulating to Improve Methadone Access

Scholars identify avenues to curb regulatory barriers to substitution therapy.

Sugar, Spice, Are Additives Nice?

Sugar, Spice, Are Additives Nice?

Scholar argues that loopholes in U.S. food regulation put consumers at risk.

Drug Safety, or Overregulation of Reproductive Health?

Drug Safety, or Overregulation of Reproductive Health?

Scholar calls for FDA to remove stringent restrictions on medication abortion.

FDA, Not a Federal Judge, Should Decide on Abortion Drugs

FDA, Not a Federal Judge, Should Decide on Abortion Drugs

Anti-abortion advocates take aim at FDA approval and regulation of the abortion drug mifepristone, threatening access nationwide.